Ultra Market Research | Global In Vitro Diagnostic Market
Global In Vitro Diagnostic Market
Report ID : 926
Category : Medical-Devices
No Of Pages : 115
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
In Vitro Diagnostics Market
Introduction
In vitro diagnostics market is the development and application of diagnostic tests and tools performed outside the human body, usually in a laboratory. Such tests identify and monitor diseases, conditions, or infections by analyzing biological samples like blood, urine, or tissues. The market has grown significantly because of the increase in prevalence of chronic diseases, advancements in diagnostics technologies, and increased healthcare expenditure. Recent trends have been the development of AI-based diagnostics, testing kits at home, and molecular diagnostics. As of 2023, the global In Vitro Diagnostics Market was estimated at around $90 billion and will grow at a compound annual growth rate of 6.5% from 2024 to 2030, which proves its importance in modern healthcare.
Segmentation
Technology
Immunoassay
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassay (CLIA)
Others
Molecular Diagnostics
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Clinical Chemistry
Basic Metabolic Panel
Lipid Panel
Others
Application
Infectious Diseases
Respiratory Infections
Sexually Transmitted Infections
Others
Chronic Diseases
Diabetes Monitoring
Cardiovascular Diagnostics
Oncology Diagnostics
Biomarker Testing
Genetic Testing
Others
End-User
Hospitals and Clinics
Specialty Clinics
Emergency Care Units
Laboratories
Independent Labs
Hospital-Affiliated Labs
Homecare Settings
At-Home Testing Kits
Online Diagnostics Platforms
List of Market Players
Roche Diagnostics (Switzerland)
Abbott Laboratories (United States)
Siemens Healthineers (Germany)
Thermo Fisher Scientific (United States)
Danaher Corporation (United States)
bioMérieux (France)
Sysmex Corporation (Japan)
Becton, Dickinson and Company (United States)
Bio-Rad Laboratories (United States)
10.PerkinElmer (United States)
11. Qiagen (Germany)
13. Ortho Clinical Diagnostics (United States)
14. Agilent Technologies (United States)
15. Hologic Inc. (United States)
16.Illumina Inc. (United States)
Drivers
The In Vitro Diagnostics Market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, which demand advanced diagnostic solutions. Furthermore, the adoption of personalized medicine is being fueled by advances in molecular diagnostics. Also, the increasing emphasis on preventive healthcare and growing demand for point-of-care testing solutions are pushing market growth. Governments around the world are investing in healthcare infrastructure, and efforts to control infectious diseases further boost the growth of the market.
Restraints
Despite the fact that the market is growing rapidly, it is still facing various challenges. Some of the key challenges include strict regulatory requirements that delay product approvals and entry into the market. High costs of advanced diagnostic tools and limited access to healthcare in developing regions pose significant barriers. Moreover, a lack of skilled professionals in some areas affects the adoption of complex diagnostics technologies. Market consolidation and intense competition also create challenges for new entrants.
Opportunities
The market offers enormous opportunities, particularly in emerging economies where healthcare infrastructure is rapidly developing. Technological advancements in AI and machine learning for diagnostics open up avenues for innovation. Growing demand for non-invasive diagnostic tests and the growing popularity of at-home testing kits offer untapped potential. Increasing collaborations between diagnostic companies and research institutions could further accelerate innovation.
Trends
The recent trends in the In Vitro Diagnostics Market include the integration of AI for predictive diagnostics and decision support systems. Point-of-care testing devices are transforming healthcare delivery by providing rapid and reliable results. Telemedicine integration with diagnostics tools enables remote patient monitoring and expands access to healthcare. Liquid biopsy tests for cancer screening and advancements in microfluidic devices are some of the notable developments shaping the future of the market.
Approved Products, Pipeline, and Pre-Regulated Products
Cobas SARS-CoV-2 Test (Roche)
Alinity System (Abbott)
VITROS XT MicroSlide (Ortho Clinical Diagnostics)
Panther Fusion System (Hologic)
BioFire FilmArray Panels (bioMérieux)
Key Target Audience
Hospitals and Clinics
Diagnostic Laboratories
Homecare Providers
Research and Academic Institutions
Healthcare Regulatory Bodies
Frequently Asked Questions (FAQ’s)
The market was valued at approximately $90 billion in 2023.
Increasing prevalence of chronic diseases, demand for personalized medicine, and advancements in molecular diagnostics.
North America holds the largest market share, followed by Europe and Asia-Pacific.
Integration of AI, growth of point-of-care testing, and rise in at-home diagnostics kits.
Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers are key market leaders.
1. Introduction
1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview
3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Treatment Type 3.2.2 By Patient Demographics 3.2.3 By Distribution Channels 3.2.4 By Therapeutic Applications 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global In Vitro Diagnostics Market by Treatment Type
5. Global In Vitro Diagnostics Market by Patient Demographics
5.1 Introduction 5.2 Market Size and Growth Rate by Patient Demographics (2024-2030) 5.2.1 Children 5.2.1.1 Infants 5.2.1.2 Toddlers and Young Children 5.2.2 Adults 5.2.2.1 Young Adults 5.2.2.2 Seniors
6. Global In Vitro Diagnostics Market by Distribution Channels
6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channels (2024-2030) 6.2.1 Hospital Pharmacies 6.2.1.1 Tertiary Care Centers 6.2.1.2 Pediatric Oncology Units 6.2.2 Retail Pharmacies 6.2.2.1 Local Pharmacies 6.2.2.2 Chain Pharmacies 6.2.3 Online Pharmacies
7. Global In Vitro Diagnostics Market by Therapeutic Applications
7.1 Introduction 7.2 Market Size and Growth Rate by Therapeutic Applications (2024-2030) 7.2.1 First-Line Treatment 7.2.1.1 Chemotherapy-Only Regimens 7.2.1.2 Targeted Therapies 7.2.2 Relapse or Refractory ALL 7.2.2.1 CAR-T Therapies 7.2.2.2 Experimental Treatments
8. Global In Vitro Diagnostics Market by Geography
8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024-2030) 8.2.1 North America 8.2.1.1 United States 8.2.1.2 Canada 8.2.2 Europe 8.2.2.1 Germany 8.2.2.2 France 8.2.2.3 United Kingdom 8.2.2.4 Rest of Europe 8.2.3 Asia Pacific 8.2.3.1 China 8.2.3.2 Japan 8.2.3.3 India 8.2.3.4 Southeast Asia 8.2.3.5 Rest of Asia Pacific 8.2.4 Latin America 8.2.4.1 Brazil 8.2.4.2 Rest of Latin America 8.2.5 Middle East & Africa (MEA) 8.2.5.1 GCC 8.2.5.2 North Africa 8.2.5.3 South Africa 8.2.5.4 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Company Profiles 9.1.1 Amgen Inc. (United States) 9.1.2 Novartis AG (Switzerland) 9.1.3 Pfizer Inc. (United States) 9.1.4 Gilead Sciences (United States) 9.1.5 Kite Pharma (United States) 9.1.6 Takeda Pharmaceutical Company (Japan) 9.1.7 Bristol-Myers Squibb (United States) 9.1.8 Jazz Pharmaceuticals (Ireland) 9.1.9 AbbVie Inc. (United States) 9.1.10 Sanofi (France) 9.1.11 Autolus Therapeutics (United Kingdom) 9.1.12 Cellectis (France) 9.1.13 Allogene Therapeutics (United States) 9.1.14 Celgene Corporation (United States) 9.1.15 Eli Lilly and Company (United States)
Table 3: Distribution Channels by Growth Rate (2024-2030)
Table 4: Regional Market Distribution
Figures:
Figure 1: Global In Vitro Diagnostics Market Growth (2024-2030)
Figure 2: Treatment Type Analysis
Figure 3: Market Share by Region
Figure 4: Competitive Landscape Overview
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results froam data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global In Vitro Diagnostics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global In Vitro Diagnostics Market for the past year and forecasts for the next six years. Global In Vitro Diagnostics Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global In Vitro Diagnostics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global In Vitro Diagnostics Market from different application industries in different regions.
